All stocks / BDTB
Bodhi Tree Biotechnology Inc BDTB
Bodhi Tree Biotechnology (BDTB): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- BODHI TREE BIOTECHNOLOGY INC
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 09
The financial report, and what it means
Annual figures to 2025-09-30- Revenue
- $17,000
- Net loss
- ($149,666)
It spends more than it earns
Under strainCustomers paid it $17,000 in the year. It lost $149,666. For every $1 that came in, about $9.80 went out.
- Cash and cash equivalents
- $109,404
- Net cash used in operating activities
- ($150,166)
The cash could run out soon
Under strainIt had $109,404 in the bank and used about $12,514 a month. At that pace the money lasts about 9 months unless it borrows or sells more shares.
- Total assets
- $119,161
- Total liabilities
- $0
It owns more than it owes
SteadyEverything the company owns adds up to $119,161. Its debts and unpaid bills add up to $0. That is about $0.00 owed for every $1 owned.
What this adds up to
2 of 3 checks show strain. It spends more than it earns. The cash could run out soon. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 25,441,042 shares as of 2026-08-14: 25,441,042 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about BDTB
Does BDTB file reports with the SEC?
Yes. Bodhi Tree Biotechnology files with the SEC under company number 0002041531. The most recent filing we hold is a 10-Q dated 2026-08-14.
Source recordHow many BDTB shares are outstanding?
25,441,042 shares as of 2026-08-14, as reported to the SEC.
Source recordHas BDTB filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is Bodhi Tree Biotechnology making money?
Customers paid it $17,000 in the year. It lost $149,666. For every $1 that came in, about $9.80 went out. (Annual figures to 2025-09-30. Facts from the company's own report, not a recommendation.)
Source record